NAD+ IU per Tick Insulin Syringe — Dosing Guide

A single tick on a standard 1mL U-100 insulin syringe represents 1 IU (International Unit), which equals 0.01mL of liquid volume. That precision matters when reconstituting NAD+. Because the difference between 50mg and 150mg of delivered peptide can come down to reading the barrel markings correctly. We've worked with hundreds of researchers navigating peptide reconstitution protocols. The most common dosing errors don't happen during injection. They happen at the syringe, where assumptions about tick spacing create multi-fold dosage miscalculations that invalidate entire experimental runs.

What does NAD+ IU per tick insulin syringe mean for peptide dosing?

Each tick mark on a 1mL U-100 insulin syringe represents 1 IU or 0.01mL of reconstituted solution. For NAD+ peptides, the actual milligram dose per tick depends entirely on your reconstitution ratio. If you dissolve 100mg of NAD+ in 2mL of bacteriostatic water, each 0.01mL tick delivers 0.5mg of the peptide. The syringe measures volume, not peptide mass. Researchers must calculate backwards from their dilution ratio to determine how many ticks deliver the target dose.

That answer tells you how the syringe works. But it leaves out the detail that derails most first-time reconstitutions: not all insulin syringes use the same tick interval. A 0.3mL syringe still shows 30 ticks from zero to full, but each tick now represents 0.01mL in a smaller total barrel. Meaning the visual spacing between ticks is three times wider than on a 1mL syringe. If you switch barrel sizes mid-protocol without recalculating, your dose triples or contracts by the same factor. This article covers the exact relationship between syringe volume, tick markings, and NAD+ dosing accuracy, the reconstitution math that determines mg per tick, and the syringe selection mistakes that compromise peptide research before a single injection occurs.

How Insulin Syringe Tick Markings Translate to NAD+ Dose

Insulin syringes are calibrated in International Units (IU), a standardisation created for insulin dosing where 1 IU corresponds to a specific biological activity of the hormone. For research peptides like NAD+, the IU marking becomes a pure volume measure. 1 IU equals 0.01mL regardless of what compound fills the barrel. The critical variable is reconstitution concentration: dissolve 200mg of NAD+ in 2mL of bacteriostatic water and each tick (0.01mL) delivers 1mg of peptide. Dilute that same 200mg in 4mL and each tick now delivers 0.5mg. The syringe hasn't changed, but the dose per tick has halved.

Most U-100 syringes display tick marks at 1-unit intervals up to 100 units (1mL total volume). Half-unit syringes exist and show 0.5 IU increments. Allowing finer dose adjustments at the cost of a busier barrel that's harder to read under poor lighting. For NAD+ research requiring doses below 5mg, half-unit syringes allow titration in 0.005mL steps rather than 0.01mL. Standard practice uses 1-unit syringes for most applications. The visual clarity outweighs the marginal precision gain unless protocol demands sub-milligram adjustments. Our experience: researchers switching to half-unit syringes without recalibrating their protocols consistently underdose by half for the first week until the error surfaces in outcome tracking.

Reconstitution Math: Calculating Milligrams per Tick for NAD+

The formula connecting syringe ticks to delivered NAD+ dose is straightforward: (Total mg of peptide ÷ Total mL of solvent) × 0.01mL = mg per tick. If you reconstitute a 500mg vial of NAD+ with 5mL of bacteriostatic water, the concentration is 100mg/mL. Each 0.01mL tick delivers 1mg of NAD+. Double the solvent to 10mL and concentration drops to 50mg/mL. Now each tick delivers 0.5mg. The syringe doesn't know what concentration you've prepared; it measures volume only. Researchers must calculate the mg-per-tick value before drawing the first dose.

Common reconstitution ratios and their corresponding tick values include 100mg in 2mL (50mg/mL, 0.5mg per tick), 200mg in 2mL (100mg/mL, 1mg per tick), and 500mg in 5mL (100mg/mL, 1mg per tick). The cleanest reconstitution for dosing accuracy uses ratios that yield whole-number mg-per-tick values. A 1mg-per-tick solution allows direct counting without fractional arithmetic mid-injection. Ratios that produce 0.33mg or 0.67mg per tick force mental math during dose preparation, increasing error probability when working under time constraints or without written calculation aids. We structure our peptide offerings to align with standard bacteriostatic water vial sizes (2mL, 5mL, 10mL) specifically to simplify this calculation step.

The Syringe Size Error That Invalidates NAD+ Dosing Protocols

Switching from a 1mL syringe to a 0.3mL syringe without recalculating tick-to-dose ratios is the single most common protocol failure in peptide research. Both syringes display 30 total tick marks. But on a 1mL barrel, 30 ticks represent 0.3mL of volume, while on a 0.3mL barrel, 30 ticks represent the full 0.3mL capacity. The visual tick spacing changes by a factor of 3.33, but the numerical labels at major increments (10, 20, 30) remain similar enough that researchers operating on autopilot read '20 ticks' and assume the same dose regardless of barrel size. The actual delivered volume differs by more than threefold.

Here's the blunt truth: if you prepare a 100mg/mL NAD+ solution and draw to the '20 tick' mark, a 1mL syringe delivers 0.2mL (20mg of NAD+) while a 0.3mL syringe delivers only 0.06mL (6mg of NAD+). The labeling looks identical. The dose is not. Most researchers discover this discrepancy only after noticing outcome inconsistencies across different syringe batches. Standardise on one barrel size per protocol and verify total capacity before calculating dose. The 0.3mL syringe offers better precision for low-volume applications (doses under 0.3mL or 30mg at 100mg/mL concentration) because each tick represents a smaller fraction of total capacity. But that advantage disappears if the researcher forgets which syringe type the protocol assumes.

NAD+ IU per Tick Insulin Syringe: Concentration vs Barrel Comparison

What If: NAD+ Dosing Scenarios with Insulin Syringes

What If I Accidentally Used a 0.3mL Syringe Instead of a 1mL Syringe?

Recalculate immediately before the next dose. If your protocol called for 20 ticks on a 1mL syringe (0.2mL) but you drew 20 ticks on a 0.3mL syringe, you delivered only 0.06mL. One-third of the intended volume. The dose discrepancy scales with your reconstitution concentration: at 100mg/mL, you gave 6mg instead of 20mg. Document the error, calculate the actual delivered dose, and determine whether the shortfall warrants adjustment in subsequent administrations or disqualifies the data point entirely depending on your research sensitivity thresholds.

What If My Reconstituted NAD+ Concentration Doesn't Align with Standard Tick Math?

Use a dose calculator or create a reference chart before beginning injections. If you reconstitute 150mg in 3mL (50mg/mL), each 0.01mL tick delivers 0.5mg. But if you need exactly 12mg per injection, that requires 24 ticks, which may exceed the practical precision of visual syringe reading. Consider re-reconstituting at a concentration that yields cleaner tick intervals (like 100mg/mL) or switching to volumetric measurement tools if your required dose falls between tick marks consistently. Forcing fractional tick counting increases user error. Adjust concentration instead.

What If I Need to Dose NAD+ Below 5mg per Injection?

Switch to a 0.3mL syringe or use a more dilute reconstitution ratio. A 0.3mL barrel allows finer visual resolution per tick, and diluting to 20mg/mL concentration means each tick delivers only 0.2mg of NAD+. Allowing doses as low as 1mg (5 ticks) with reasonable accuracy. For microdosing research requiring sub-milligram precision, half-unit syringes combined with 10mg/mL or 20mg/mL solutions provide the necessary granularity without resorting to Hamilton microliter syringes.

The Unforgiving Truth About Syringe Dosing Errors in Peptide Research

Here's the honest answer: most peptide dosing errors don't happen because researchers lack precision. They happen because researchers assume precision where none exists. An insulin syringe is a volume measurement tool calibrated for a specific use case (insulin at standardised concentrations). When repurposed for peptides like NAD+, every assumption about 'one tick equals one dose' breaks unless you've done the reconstitution math to make that true. The syringe doesn't adjust for your concentration. It doesn't flag when you've switched barrel sizes. It measures liquid volume with ruthless accuracy and leaves interpretation entirely to the user. If you reconstitute at 73mg/mL because that's what the vial size forced, each tick delivers 0.73mg. And you either accept fractional arithmetic for every injection or re-reconstitute at a ratio that yields whole numbers.

Researchers who chase 'maximum peptide utilisation' by dissolving vials in the minimum solvent volume often create concentrations that don't divide cleanly into syringe tick intervals. That 500mg vial dissolved in 4.7mL of bacteriostatic water saves 0.3mL of solvent but produces a 106.4mg/mL solution where calculating dose-per-tick requires a calculator mid-protocol. The time saved on solvent is lost ten times over in dose verification steps. Standard reconstitution ratios exist for a reason. They align peptide concentration with insulin syringe graduations to make tick-counting arithmetically clean. Our peptide catalog at Real Peptides is structured around vial sizes that pair with common bacteriostatic water volumes (2mL, 5mL, 10mL) specifically to eliminate this friction.

Verifying NAD+ Dose Accuracy Beyond Tick Counting

Tick marks provide visual reference, but the definitive dose verification method is total drawn volume measured by barrel position relative to the plunger. After drawing to your target tick count, confirm the plunger sits at the corresponding volumetric mark. If you aimed for 20 ticks (0.2mL) on a 1mL syringe, the fluid line should align with the 20-unit label and the total liquid column should measure 0.2mL when read against the barrel's mL graduations if present. Syringes with dual labeling (IU and mL) allow cross-verification; those with IU-only markings require users to convert mentally or use reference charts.

Another layer of verification involves pre-drawing a known volume of sterile water and confirming tick count matches expected volume before introducing peptide into the workflow. Draw exactly 0.1mL of water using volumetric measurement, then count the ticks. A 1mL syringe should show 10 ticks. This one-time calibration check catches mislabeled or non-standard syringes before they compromise peptide doses. We recommend this step for any new syringe supplier or batch, especially when sourcing internationally where manufacturing tolerances may differ from USP standards. Peptide research compounds like Dihexa and Cerebrolysin require the same dosing precision as NAD+. One miscalibrated syringe invalidates an entire experimental series.

Understanding NAD+ IU per tick insulin syringe mechanics isn't optional knowledge. It's the foundation that separates reproducible peptide research from guesswork. Every tick represents 0.01mL of volume, but only reconstitution math determines how many milligrams of NAD+ that volume contains. Syringe barrel size, concentration ratios, and tick interval all interact to define dose accuracy. Researchers who treat the syringe as a passive measurement tool rather than an active variable in their protocol consistently produce cleaner data with fewer unexplained outcome variances. If your current reconstitution approach requires fractional tick counting or mental unit conversions mid-injection, the protocol needs adjustment. Not more careful syringe reading.